Basis of Presentation and Summary of Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2022

Accounting Policies [Abstract]

Schedule of Revenue Disaggregated by Product and Service Type

The following table shows revenue disaggregated by product and service type for the three and nine months ended September 30, 2022 and 2021 (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Scilex Pharmaceuticals Inc. product sales	$	11,377	$	7,525	$	26,115	$	22,313
Sorrento Therapeutics, Inc. product revenues		2,272		37		6,116		126
Net product revenues	$	13,649	$	7,562	$	32,231	$	22,439
Concortis Biosystems Corporation	$	1,818	$	3,164	$	8,435	$	12,094
Bioserv Corporation		540		968		2,007		3,549
Other service revenues		1,393		368		4,572		1,746
Service revenues	$	3,751	$	4,500	$	15,014	$	17,389